Otsuka Pharmaceutical Companies (U.S.) nelle notizie
Sviluppo e commercializzazione farmaceutica
Tamtam ha trovato 16 articoli recenti su Otsuka Pharmaceutical Companies (U.S.).
- (sibeprenlimab-szsi) Preserved Kidney Function Over 12 Months in IgA Nephropathy (IgAN)
- Otsuka Presents New Phase 3 Post Hoc Analyses of Centanafadine Highlighting Improvement in Executive Function and Emotional Dysregulation in Adults with ADHD at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
- Otsuka Pharmaceutical to acquire Transcend Therapeutics in $700M deal
- Otsuka Pharmaceutical to Acquire Transcend Therapeutics
- Leading in the Psychedelic Space: Q&A with Tarek Rabah
- Japanese Pharmas Looking Beyond Borders for M&A to US, EU
- FDA approves Otsuka kidney disease therapy
- US FDA approves Otsuka's drug for a type of kidney disease
- Otsuka Pharmaceutical acquires Cantargia's CAN10 program in a deal worth over $600 million
- Otsuka Pharmaceutical acquires Cantargia's CAN10 program in a deal worth over USD 600 million
- Lupin shares gain 4% on Tolvaptan Tablets launch in US; details here
- Pharmavite Established a New Facility in Ohio, US, Dedicated to The Manufacturing of Gummy SupplementsFacilitating the Research and Development of Gummy Products｜May 9, 2025｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- CEO of Otsuka North America: Are We Getting better access with AI?
- Otsuka America, Inc’s. Data and Technology Company will Support Rejoyn™ Commercialization & Personalized Patient Engagement
- Otsuka Pharmaceutical Companies US Welcomes Jane Urban as VP of Customer Engagement Operations
- Schizophrenia Drugs Market Size | Industry Report, 2030
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Otsuka Pharmaceutical Companies (U.S.)?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili